Large scale validation of an early-age eye-tracking biomarker of an autism spectrum disorder subtype

Few clinically validated biomarkers of ASD exist which can rapidly, accurately, and objectively identify autism during the first years of life and be used to support optimized treatment outcomes and advances in precision medicine. As such, the goal of the present study was to leverage both simple an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Teresa H., Cheng, Amanda, Andreason, Charlene, Zahiri, Javad, Xiao, Yaqiong, Xu, Ronghui, Bao, Bokan, Courchesne, Eric, Barnes, Cynthia Carter, Arias, Steven J., Pierce, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917231/
https://www.ncbi.nlm.nih.gov/pubmed/35277549
http://dx.doi.org/10.1038/s41598-022-08102-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917231/
https://www.ncbi.nlm.nih.gov/pubmed/35277549
http://dx.doi.org/10.1038/s41598-022-08102-6

Ejemplares similares